Cargando…

A pragmatic dementia risk score for patients with mild cognitive impairment in a memory clinic population: Development and validation of a dementia risk score using routinely collected data

INTRODUCTION: This study aimed to develop and validate a 3‐year dementia risk score in individuals with mild cognitive impairment (MCI) based on variables collected in routine clinical care. METHODS: The prediction score was trained and developed using data from the National Alzheimer's Coordin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Meng, Sajobi, Tolulope T., Ismail, Zahinoor, Seitz, Dallas, Chekouo, Thierry, Forkert, Nils D., Fischer, Karyn, Mackie, Aaron, Pearson, Dawn, Patry, David, Cieslak, Alicja, Menon, Bijoy, Barber, Philip, McLane, Brienne, Granger, Robert, Hogan, David B., Smith, Eric E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092734/
https://www.ncbi.nlm.nih.gov/pubmed/35592692
http://dx.doi.org/10.1002/trc2.12301
Descripción
Sumario:INTRODUCTION: This study aimed to develop and validate a 3‐year dementia risk score in individuals with mild cognitive impairment (MCI) based on variables collected in routine clinical care. METHODS: The prediction score was trained and developed using data from the National Alzheimer's Coordinating Center (NACC). Selection criteria included aged 55 years and older with MCI. Cox models were validated externally using two independent cohorts from the Prospective Registry of Persons with Memory Symptoms (PROMPT) registry and the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. RESULTS: Our Mild Cognitive Impairment to Dementia Risk (CIDER) score predicted dementia risk with c‐indices of 0.69 (95% confidence interval [CI] 0.66–0.72), 0.61 (95% CI 0.59–0.63), and 0.72 (95% CI 0.69–0.75), for the internally validated and the external validation PROMPT, and ADNI cohorts, respectively. DISCUSSION: The CIDER score could be used to inform clinicians and patients about the relative probabilities of developing dementia in patients with MCI.